Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,520,826
-
Share change
-
+1,274,868
-
Total reported value
-
$60,530,502
-
Price per share
-
$13.39
-
Number of holders
-
45
-
Value change
-
+$16,896,058
-
Number of buys
-
30
-
Number of sells
-
8
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q3 2016
As of 30 Sep 2016,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,520,826 shares.
The largest 10 holders included
Vivo Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., RA CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, NEXTHERA CAPITAL LP, SABBY MANAGEMENT, LLC, Lombard Odier Asset Management (USA) Corp, VANGUARD GROUP INC, Boxer Capital, LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.